These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17443030)

  • 21. Cost-effectiveness of medical primary prevention strategies to reduce absolute risk of cardiovascular disease in Tanzania: a Markov modelling study.
    Ngalesoni FN; Ruhago GM; Mori AT; Robberstad B; Norheim OF
    BMC Health Serv Res; 2016 May; 16():185. PubMed ID: 27184802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholesterol, cholesterol-lowering agents/statins, and urologic disease: Part V--Statins versus aspirin for primary prevention, and the winner is...?
    Moyad MA; Merrick GS
    Urol Nurs; 2007 Apr; 27(2):166-8. PubMed ID: 17494461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of aspirin among diabetics in the primary prevention of cardiovascular disease: need for reliable randomized evidence and astute clinical judgment.
    Hebert PR; Schneider WR; Hennekens CH
    J Gen Intern Med; 2009 Nov; 24(11):1248-50. PubMed ID: 19771482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Don't use aspirin for primary prevention of cardiovascular disease.
    Barnett H; Burrill P; Iheanacho I
    BMJ; 2010 Apr; 340():c1805. PubMed ID: 20410163
    [No Abstract]   [Full Text] [Related]  

  • 25. False profits and silent partners in health care.
    Lands B
    Nutr Health; 2009; 20(2):79-89. PubMed ID: 19835105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preventing cancer, cardiovascular disease, and diabetes: a common agenda for theAmerican Cancer Society, the American Diabetes Association, and the American Heart Association.
    Eyre H; Kahn R; Robertson RM;
    CA Cancer J Clin; 2004; 54(4):190-207. PubMed ID: 15253917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-dose acetylsalicylic acid for primary prevention of cardiovascular disease: Do not misinterpret the recommendations.
    Truong C
    Can Fam Physician; 2015 Nov; 61(11):971-5. PubMed ID: 26564657
    [No Abstract]   [Full Text] [Related]  

  • 28. Aspirin for primary prevention of cardiovascular disease events.
    Nemerovski CW; Salinitri FD; Morbitzer KA; Moser LR
    Pharmacotherapy; 2012 Nov; 32(11):1020-35. PubMed ID: 23019080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association.
    Eyre H; Kahn R; Robertson RM; Clark NG; Doyle C; Hong Y; Gansler T; Glynn T; Smith RA; Taubert K; Thun MJ; ; ;
    Circulation; 2004 Jun; 109(25):3244-55. PubMed ID: 15198946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multi-country economic evaluation of low-dose aspirin in the primary prevention of cardiovascular disease.
    Lamotte M; Annemans L; Evers T; Kubin M
    Pharmacoeconomics; 2006; 24(2):155-69. PubMed ID: 16460136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aspirin for primary prevention of cardiovascular disease (revisited).
    Med Lett Drugs Ther; 2006 Jul; 48(1238):53. PubMed ID: 16841021
    [No Abstract]   [Full Text] [Related]  

  • 32. [Primary cardiovascular prevention with aspirin].
    Seguí Díaz M; Escobar C; Divisón JA
    Semergen; 2015; 41(5):279-81. PubMed ID: 25622997
    [No Abstract]   [Full Text] [Related]  

  • 33. [Primary prevention of coronary heart disease? What is cost effective in the clinical practice?].
    Kübler W
    Z Kardiol; 2005; 94 Suppl 3():III/92-9. PubMed ID: 16258799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aspirin for the Primary Prevention of Cardiovascular Disease: In Need of Clarity.
    Miedema MD; Huguelet J; Virani SS
    Curr Atheroscler Rep; 2016 Jan; 18(1):4. PubMed ID: 26753770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advancing the science of aspirin in primary prevention of vascular events.
    Cardiovasc J Afr; 2007; 18(5):347-8. PubMed ID: 17985039
    [No Abstract]   [Full Text] [Related]  

  • 36. Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.
    Morimoto T; Fukui T; Lee TH; Matsui K
    Am J Med; 2004 Oct; 117(7):459-68. PubMed ID: 15464702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspirin for primary prevention: yes or no?
    Selak V; Elley CR; Wells S; Rodgers A; Sharpe N
    J Prim Health Care; 2010 Jun; 2(2):92-9. PubMed ID: 20690297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost and effectiveness of cardiovascular prevention.
    Boyar A
    Am J Cardiol; 2007 Nov; 100(9):1492-4; author reply 1494-5. PubMed ID: 17950815
    [No Abstract]   [Full Text] [Related]  

  • 39. [The role of aspirin in the primary prevention of cardiovascular disease].
    Rodondi N; Cornuz J
    Rev Med Suisse; 2006 Mar; 2(56):646-51. PubMed ID: 16597054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aspirin therapy and primary prevention of cardiovascular disease in diabetes mellitus.
    Younis N; Williams S; Soran H
    Diabetes Obes Metab; 2009 Nov; 11(11):997-1000. PubMed ID: 19531055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.